Standard BioTools
LAB
LAB
158 hedge funds and large institutions have $387M invested in Standard BioTools in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 46 increasing their positions, 51 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
10% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 51
25% less call options, than puts
Call options by funds: $51K | Put options by funds: $68K
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
158
Holding in Top 10
2
Calls
$51K
Puts
$68K
Top Buyers
| 1 | +$15.1M | |
| 2 | +$4.51M | |
| 3 | +$2.6M | |
| 4 |
Morgan Stanley
New York
|
+$1.8M |
| 5 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
+$1.77M |
Top Sellers
| 1 | -$1.42M | |
| 2 | -$1.42M | |
| 3 | -$1.14M | |
| 4 |
Goldman Sachs
New York
|
-$1.03M |
| 5 |
JC
JBF Capital
Aspen,
Colorado
|
-$1M |
